Effect of cytokines secreted from Kupffer cell on HSC proliferation, apoptosis in hepatic fibrosis process

Chinese Pharmacological Bulletin

Volumn 26, Issue 1, 2010, Pages 9-13

  Huang, Yan ^a   Huang, Cheng ^a   Li, Jun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cytokine; Hepatic fibrosis; HSC; Kupffer cell; Proliferation

Indexed keywords

CYTOKINE;

APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL INTERACTION; CELL PROLIFERATION; CYTOKINE RELEASE; DISEASE COURSE; EXTRACELLULAR MATRIX; KUPFFER CELL; LIVER FIBROSIS; STELLATE CELL;

EID: 77951837088     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Shek F W, Benyon R C. How can transforming growth factor beta be targeted usefully to combat liver fibrosis[J]? Eur J Gastroenterol Hepatol,2004,16:123- 126
2. 4-induced hepatic fibrosis rats[J]. Chin Pharmacol Bull,2009,25(6):761-764
3. Cheng K, Yang N, Mahato R I. TGF-beta1 gene silencing for treating liver fibrosis[J]. Mol Pharm,2009,6(3):772-779
4. Si H F, Li J, Lü X, et al. Suppressive effect of leflunomide on rat hepatic stellate cell proliferation involves on PDGF-BB-elicited activation of three mitogen-activated protein kinases[J]. Cytokine,2008,42:24-31.
5. Tomita K, Tamiya G, Ando S, et al. Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-altoholic steatohepatitis in mice[J]. Gut,2006,55:415-424 (Pubitemid 43268283)
6. Migita K, Maeda Y, Abiru S, et al. Immunosuppressant FK506 inhibits matrix metalloproteinase-9 induction in TNF-alpha-stimulated human hepatic stellate cells[J]. Life Sci,2006,78(21):2510-5.
7. Novo E, Marra F, Zamara E, et al. Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans[J]. Gut,2006,55(8):1174-1182 (Pubitemid 44085687)
8. Wan R, Wu Y L, Qiao M M, et al. Effect of insulin-like growth factor-1 on hepatic fibrosis in rats[J]. World Chin J Digestol,2005,13(2):211-213 (Pubitemid 40459163)
9. Liu L X, Zhang Q Q, Han D W, et al. Expression of IGFBP2 and IGFBP6 in TGF-β1 activated HSC[J]. Chin J Pathophysiol, 2008,24(12):2481-2483
10. Vera M, Sobrevals L, Zaratiegui M, et al. Liver transduction with a simian virus 40 vector encoding insulin-like growth factor I reduces hepatic damage and the development of liver cirrhosis[J]. Gene Ther,2007,14(3):203-210 (Pubitemid 46152623)
11. Xu Y, Du W J, Qin L Y, et al. Expression of interleukin-17 in hepatitis B related liver fibrosis[J]. Chin J Cell Mol Immunol,2009,25(2):133-135
12. Zheng W D, Zhang L J, Shi M N, et al. Expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in hepatic stellate cells during rat hepatic fibrosis and its intervention by IL-10[J]. World J Gastroenterol,2005,11(12):1753-1758
13. Tang X, Yang J, Li J. Sensitization of human hepatic stellate cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by leflunomide[J]. Biol Pharm Bul,2009,32(6):963-7.
14. 4-induced liver injury and fibrosis[J]. Am J Physiol Gastrointest Liver Physiol, 2007,293(3):G631-9. (Pubitemid 47435392)
15. Bethanis S K, Theocharis S E. Leptin in the field of hepatic fibrosis:pivotal or an incidental player[J]? Dig Dis Sci,2006,51(10):1685-1696
16. Honda H, Ikejima K, Yoshikawa M, et al. Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver[J]. Hepatology,2002, 36(1):12-21. (Pubitemid 34700757)
17. Nong B, Luo H S, Liang Z W, et al. Relationship between leptin and liver fibrogenesis of rats[J]. Acta Med Sin,2006,19(3):386-8.
18. Wang J, Leclercq I, Brymora J M, et al. kupffer cells mediate leptin-induced liver fibrosis[J]. Gastroenterology,2009,137(2):713-23.
19. Si H F, Li J, Lü X, et al. Suppressive effects of leflunomide on leptin-induced collagen I production involved in hepatic stellate cell proliferation[J]. Exp Biol Med,2007,232(3):427-436
20. Li J, Si HF, Lü X, et al. Suppressive effects of leflunomide on leptin-induced TIMP-1 production involves on hepatic stellate cell proliferation and apoptosis[J]. Eur J Pharmacol,2008,580(1-2):63-69
21. Kumada M, Kihara S, Ouchi N, et al. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages[J]. Circulation, 2004,109(17):2046-2049 (Pubitemid 38620209)
22. Liu J, Gong H, Zhang Z T, et al. Effect of angiotensin II and angiotensin II type 1 receptor antagonist on the proliferation, contraction and collagen synthesis in rat hepatic stellate cells[J]. Chin Med J (Engl),2008,121(2):161- 165
23. Bezugla Y, Kolada A, Kamionka S, et al. COX-1 and COX-2 contribute differentially to the LPS-induced release of PGE2 and TxA2 in liver macrophages[J]. Prostaglandins Other Lipid Mediat, 2006,79(1-2):93-100. (Pubitemid 43306853)
24. Gaca M D, Zhou X, Issa R, et al. Basement membrane-like matrix inhibits proliferation and collagen synthesis by activatedrat hepatic stellate cells:evidence for matrixdependent deactivation of stellate cells[J]. Matrix Biol,2003,22:229-239 (Pubitemid 36802365)
25. Duffield J S, Forbes S J, Constandinou C M, et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair[J]. J Clin Invest,2005,115(1):56-65.
26. Fischer R, Cariers A, Reinehr R, et al. Caspase 9-dependent killing of hepatic stellate cells by activated Kupffer cells[J]. Gastroenterology,2002, 123(3):845-861 (Pubitemid 34977091)
27. Friedman S L. Mac the knife? Macrophages - the double-edged sword of hepatic fibrosis[J]. J Clin Invest,2005,115(1):29-32.
28. Ping J, Cheng Y, Xu L M. Curcumin induces apoptosis of hepatic stellate cells by activating peroxisome proliferator-activated receptor γ signal[ J]. Chin Pharmacol Bull,2001,23(10):1295-1299
29. Zhang Y, Ping J, Wang H. The research progress of hepatic stellate cell's apoptosis signaling pathway and the relative drugs[J]. Chin Pharmacol Bull,2009,25(1):16-18
30. Sun L B, Wang W P, Gu Z L, et al. Wnt signalling pathway and hepatic fibrosis[J]. Chin Pharmacol Bull,2008,24(7):861-864
31. Tang X, Yang J, Li J. Accelerative effect of leflunomide on recovery from hepatic fibrosis involves TRAIL-mediated hepatic stellate cell apoptosis[J]. Life Sci,2009,84(15-16):552-557
32. Mahalingam D, Szegezdi E, Keane M, et al. TRAIL receptor signalling and modulation:Are we on the right TRAIL[J]? Cancer Treat Rev,2009,35(3):280-288